Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

Illumina Inc (ILMN) reports steady revenue growth and strategic advancements, while addressing competitive pressures and geopolitical risks.

Q4 2024 Earnings Call Transcript February 6, 2025 Illumina, Inc. misses on earnings expectations. Reported EPS is $0.91 EPS, ...

The U.S. tariffs on China include a broad 10% levy on imported goods. China’s response was more targeted, with 15% tariffs on ...

After China placed Illumina on a government watchlist this week, in response to new tariffs imposed by the Trump ...

以下简称Illumina）列入不可靠实体清单。 记者注意到，Illumina是一家基因测序试剂设备供应商，此前与国内部分基因测序公司有合作关系，与华大 ...

The headline numbers for Illumina (ILMN) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street ...

Q4 2024 Management View CEO Jacob Thaysen highlighted the transformative progress Illumina made in 2024, emphasizing its strategic roadmap targeting high single-digit revenue growth by 2027. He noted ...

Feb 4 (Reuters) - Shares of genetic testing company Illumina (ILMN.O), opens new tab and Calvin Klein-owner PVH Corp (PVH.N), opens new tab fell on Tuesday after ...

Illumina (NASDAQ:ILMN – Get Free Report) is anticipated to announce its earnings results after the market closes on Thursday, February 13th. Analysts expect the company to announce earnings of $0.92 ...

Investing.com -- TD Cowen downgraded Illumina Inc (NASDAQ: ILMN) to "Hold" following the company's fourth-quarter earnings, ...

Illumina (NASDAQ:ILMN – Free Report) had its target price trimmed by Barclays from $145.00 to $130.00 in a research report report published on Monday morning,Benzinga reports. The brokerage currently ...